The Limited Times

Now you can see non-English news...

The US FDA is discussing the approval of the third vaccine dose against Corona Israel today

2021-09-17T15:00:50.349Z

Dr. Elrai Price presents the efficacy data of the booster • A new study at the Weizmann Institute shows high efficacy in preventing infection and serious illness for Pfizer's third vaccine



The U.S. Food and Drug Administration today (Friday) began discussing the question of approving the third dose of Pfizer vaccine for corona 16 and older.

The head of the health services in Israel, Dr. Elrai Price, presented the efficiency data of the booster in Israel.

The discussion revolves around, among other things, the question of whether there is enough evidence that a third vaccine cream is also needed for young people, while there is already enough evidence that it increases protection for those aged 65 and over.

Meanwhile, a new study by a team of researchers from the Weizmann Institute of Science, the Ministry of Health, the Technion, the Hebrew University, the Gartner Institute at Sheba Medical Center and the KI Institute shows high efficacy of a third Pfizer vaccine - both in preventing and preventing serious disease.

Findings published in the New England Journal of Medicine show that a third dose has more than ten times improved the immune protection of its recipients compared to those who were vaccinated with only two doses five months ago or more. 

Source: israelhayom

All news articles on 2021-09-17

Similar news:

You may like

News/Politics 2021-09-22T06:13:58.042Z

Trends 24h

News/Politics 2021-10-11T07:49:42.124Z
News/Politics 2021-10-10T17:49:02.018Z

Latest

© Communities 2019 - Privacy